Abbott’s stock falls by nearly 11% following Q4 sales miss
Abbott’s stock has fallen by over 7% despite reporting strong fiscal year 2025 (FY25) revenues of $44.32bn, representing a 5.7% …
Abbott’s stock has fallen by over 7% despite reporting strong fiscal year 2025 (FY25) revenues of $44.32bn, representing a 5.7% …
Kardium has unveiled further results from the pivotal trial of its Globe Pulsed Field System, demonstrating the system’s success in …
Becton, Dickinson and Company (BD) and Ypsomed have announced an expansion of their partnership with the development of a 5.5ml …
SonoMotion has received the US Food and Drug Administration (FDA) 510(k) clearance for its Break Wave non-invasive kidney stone treatment …
SurGenTec’s ION-C facet fixation system, an implantable screw used to stabilise the posterior cervical spine’s (neck) facet joints during spinal …
Abbott has gained a CE mark in the European Union (EU) for the TactiFlex Duo ablation catheter, representing the company’s …
The Gates Foundation and OpenAI are launching a $50m initiative to roll out artificial intelligence (AI) across countries in Africa …
Cepheid has received clearance from the US Food and Drug Administration (FDA) for its Xpert GI Panel, a multiplex polymerase …
QT Imaging has signed an exclusive distribution agreement with Al Naghi Medical (NMC) for its QTI Breast Acoustic CT [computed …
A new survey by security firm Imprivata has found that a majority of IT leaders in healthcare view ‘passwordless’ authentication …
The use of mobile devices in hospitals to streamline workflows and improve patient care has become commonplace. For cyber-attackers, this …
Amid a more politically charged healthcare landscape, Fresenius’ CEO has called for a “fundamental rethink” to deliver healthcare systems that …
The UK Dementia Research Institute (DRI) has announced an international research study, which is underway to assess whether a finger-prick …
Guardant Health has entered a multi-year strategic partnership agreement with Merck & Co (MSD) for the development of companion diagnostics. The …
Organon’s Nexplanon implant for preventing unwanted pregnancy can now be used for up to five years after the company gained …